Experiences with long acting injectable ART: A qualitative study among PLHIV participating in a Phase II study of cabotegravir + rilpivirine (LATTE-2) in the United States and SpainDeanna Kerrigan, Miranda Murray, Miguel Górgolas et al.|PLoS ONE|2018Cited by 179